Medicine & Life Sciences
IGF Type 1 Receptor
100%
Breast Neoplasms
89%
Somatomedins
63%
Insulin Receptor
57%
Insulin-Like Growth Factor I
57%
procathepsin D
50%
Maltose-Binding Proteins
48%
Aspartic Acid Proteases
46%
Somatomedin Receptors
44%
Neoplasms
39%
Neoplasm Metastasis
38%
Down-Regulation
36%
Pepsinogen A
32%
Single-Chain Antibodies
29%
Antibodies, Monoclonal, Humanized
29%
Antibodies
28%
Growth
28%
Bacterial Proteins
27%
MCF-7 Cells
24%
Tamoxifen
23%
Solubility
22%
figitumumab
21%
Inclusion Bodies
20%
Therapeutics
20%
Insulin-Like Growth Factor II
19%
perlecan
16%
Clinical Trials
16%
Interleukin-4 Receptors
16%
Insulin Antibodies
15%
Quantum Dots
15%
Chimeric Antigen Receptors
15%
Immunotoxins
15%
In Vitro Techniques
14%
Triple Negative Breast Neoplasms
13%
Fibroblast Growth Factors
13%
Cell Proliferation
12%
AVE1642
12%
Receptor Protein-Tyrosine Kinases
11%
Heterografts
11%
Osteoclasts
11%
Integrins
11%
Epidermal Growth Factor
10%
Insulin
10%
Sarcoma
10%
Doxorubicin
10%
Transcriptional Activation
10%
Escherichia coli
9%
Proteins
9%
Lung
8%